SCHEMBL14028019

SCHEMBL14028019

Cc1cccc(C(=O)Nc2nc(-c3ccc(C(=O)N[C@H](C(=O)N4CCCC4)c4ccccc4)cc3)cs2)c1-c1ccc(C(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTTP P55157 9/20 0.51
KDM4E B2RXH2 2/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
PPARG P37231 1/20 0.45
KMT2A Q03164 1/20 0.45
NCOA2 Q15596 1/20 0.45
NCOA1 Q15788 1/20 0.45
NCOA3 Q9Y6Q9 1/20 0.45
SCD O00767 1/20 0.42
KLRK1 P26718 1/20 0.42
MICA Q29983 1/20 0.42
RAET1L Q5VY80 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
PHGDH O43175 1/20 0.42
NAMPT P43490 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14028012 0.92 MTTP (0.54) MTTPKDM4EMAPTMEN1ALDH1A1
SCHEMBL14028018 0.91 MTTP (0.57) MTTPKDM4EMAPTMEN1ALDH1A1
SCHEMBL14027948 0.87 MTTP (0.54) MTTPKDM4EMAPTMEN1ALDH1A1
SCHEMBL14028026 0.85 ROCK2 (0.44) MTTPKDM4EMAPTMEN1ALDH1A1
SCHEMBL14028008 0.83 MTTP (0.46) MTTPKDM4EMAPTMEN1KMT2A
SCHEMBL14028021 0.83 MTTP (0.47) MTTPKDM4EMAPTSCDADORA3
SCHEMBL4941159 0.83 MTTP (0.60) MTTPKDM4EMAPTMEN1ALDH1A1
SCHEMBL4941165 0.83 MTTP (0.60) MTTPKDM4EMAPTMEN1ALDH1A1
SCHEMBL14046271 0.81 MTTP (0.46) MTTPKLRK1MICARAET1L
SCHEMBL14028004 0.79 MTTP (0.46) MTTPMAPTLMNAKLRK1MICA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249130-A1 Gut microsomal triglyceride transport protein inhibitors SIRTRIS PHARMACEUTICALS, INC. (US) 2008-10-09 US disclosed
WO-2008100423-A1 GUT MICROSOMAL TRIGLYCERIDE TRANSPORT PROTEIN INHIBITORS SIRTRIS PHARMACEUTICALS, INC. (US) 2008-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249130-A1 Gut microsomal triglyceride transport protein inhibitors MTTP, CETP, FABP2 MTTP 1/4885KDM4E 2386/4885MAPT 2403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.